Pfizer Inc - Mar 17, 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
10%+ Owner
Signature
/s/ Susan Grant, Assistant Secretary
Stock symbol
PYXS
Transactions as of
Mar 17, 2023
Transactions value $
$4,999,999
Form type
4
Date filed
3/21/2023, 06:07 PM
Previous filing
Dec 29, 2022
Next filing
Mar 30, 2023
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock, $0.001 par value per share Purchase $5M +1.81M +43.75% $2.76 5.95M Mar 17, 2023 Direct
holding PYXS Common Stock, $0.001 par value per share 1.08M Mar 17, 2023 By Pfizer Ventures (US) LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.